| Structure | Chemical Name | CAS | MF |
|
N-(TRANS-4-TERT-BUTYL-CYCLOHEXYL)CARBONYL-D-PHENYLALANINE
|
105746-46-1
|
C20H29NO3
|
|
Nateglinide Methyl Ester
|
105746-47-2
|
C20H29NO3
|
|
BRASSININ
|
105748-59-2
|
C11H12N2S2
|
|
6-O-decanoyl-3,4-di-O-isobutyrylsucrose
|
105749-78-8
|
C30H52O14
|
|
BOC-O-DIPHENYLPHOSPHO-L-SERINE
|
105751-07-3
|
C20H24NO8P
|
|
FMOC-SER(TBU)-OPFP
|
105751-13-1
|
C28H24F5NO5
|
|
NEPSILON-FMOC-NALPHA-CBZ-L-LYSINE, 98
|
105751-18-6
|
C29H30N2O6
|
|
FMOC-D-PIPECOLIC ACID
|
105751-19-7
|
C21H21NO4
|
|
2-Amino-3,5-dichloro-6-bromopyridine
|
105751-20-0
|
C5H3BrCl2N2
|
|
Phosphoric acid dodecyl 2-hydroxy-3-methacryloyloxypropyl(sodium) salt
|
105751-30-2
|
|
|
tert-Butyl 2-[2-(aminocarbonyl)-1-pyrrolidinyl]-2-oxo-1-([2-(trifluoro methyl)-1H-imidazol-5-yl]methyl)ethylcarbamate
|
105751-69-7
|
|
|
4-IODO-3-NITROANILINE
|
105752-04-3
|
C6H5IN2O2
|
|
4-IODO-3-NITRO-N,N-DIMETHYLANILINE
|
105752-05-4
|
C8H9IN2O2
|
|
3-Amino-4-iodopyridine
|
105752-11-2
|
C5H5IN2
|
|
5-ETHYNYL-2-METHOXY-PHENYLAMINE
|
105752-19-0
|
C9H9NO
|
|
1-METHYL-6-NITRONAPHTHALENE
|
105752-67-8
|
C11H9NO2
|
|
valyl-tyrosyl-prolyl-asparaginyl-glycyl-alanine
|
105760-58-5
|
|
|
NK-611 hydrochloride
|
105760-98-3
|
C31H37NO12.ClH
|
|
GYPSOGENIN-3-GLUCORONIDE
|
105762-16-1
|
C36H54O10
|
|
1H-Pyrrole,1-(4-pentynyl)-(9CI)
|
105763-05-1
|
C9H11N
|
|
(R)-2-Aminobut-3-enoic acid hydrochloride
|
105763-41-5
|
C4H8ClNO2
|
|
2,4-Dichloro-6-methoxyquinazoline
|
105763-77-7
|
C9H6Cl2N2O
|
|
5-ForMyl-2-Methoxy-benzenesulfonaMide
|
105764-07-6
|
C8H9NO4S
|
|
(+)-1-(9-FLUORENYL)ETHYL CHLOROFORMATE
|
105764-39-4
|
C16H13ClO2
|
|
ETHYL 5-OXO-5-(4-PHENOXYPHENYL)VALERATE
|
105769-45-7
|
C19H20O4
|
|
N-[3-(1-IMidazolyl)propyl]-4-chlorobenzenesulfonaMide
|
105771-36-6
|
C12H14ClN3O2S
|
|
3,6-Dihydro-2H-pyran-4-carbonitrile
|
105772-13-2
|
C6H7NO
|
|
2H-Pyran-4-carboxylicacid,3,6-dihydro-,methylester(9CI)
|
105772-14-3
|
C7H10O3
|
|
(1alpha,2alpha,3aalpha,8abeta)-(-)-1,2,3,3a,4,7,8,8a-Octahydro-3a,6-dimethyl-1-(1-methylethyl)- 1,2-azulenediol
|
105772-90-5
|
C15H26O2
|
|
2-(2-aMinothiazol-5-yl)ethanol
|
105773-93-1
|
C5H8N2OS
|
|
5-(2-AMinoethyl)thiazol-2-aMine dihydrochloride
|
105774-05-8
|
C5H9N3S
|
|
3-(4-chlorophenyl)-9-methyl-1,4-dihydro[1,2,4]triazino[3,4-f]purine-6,8(7H,9H)-dione
|
105774-49-0
|
C14H11ClN6O2
|
|
1-IODONONAFLUORO(3-METHYLBUT-1-ENE)
|
105774-97-8
|
C5F9I
|
|
4,6-DIMETHOXY-1H-INDOLE-2-CARBOXYLIC ACID
|
105776-11-2
|
C11H11NO4
|
|
METHYL 4,6-DIMETHOXY-2-INDOLECARBOXYLATE
|
105776-13-4
|
C12H13NO4
|
|
(2S)-2-(1-oxo-2,3-dihydro-1H-isoindol-2-yl)-3-phenylpropanoic acid
|
105776-76-9
|
C17H15NO3
|
|
AC-MET-GLU-OH
|
105777-14-8
|
C12H20N2O6S
|
|
PYRIMIDIFEN
|
105779-78-0
|
C20H28ClN3O2
|
|
(S)-3-[4-(2-Methoxyethyl)phenoxy]-1,2-epoxypropane
|
105780-38-9
|
C12H16O3
|
|
3,10-Dichloro-5,12-dihydro-2-(1,3-dioxoisoindolin-2-yl)methyl-5,12-diazapentacene-7,14-dione
|
105781-20-2
|
|
|
TETRAKIS(OCTADECYLTHIO)TETRATHIAFULVALENE
|
105782-53-4
|
C78H148S8
|
|
Cyclopropanecarboxylic acid, 2-fluoro-2-methoxy-, methyl ester, cis- (9CI)
|
105783-72-0
|
C6H9FO3
|
|
Cyclopropanecarboxylic acid, 2-fluoro-2-methoxy-, methyl ester, trans- (9CI)
|
105783-74-2
|
C6H9FO3
|
|
Furo[2,3-b]pyridine, 2,3-dihydro-5,6-dimethyl- (9CI)
|
105783-85-5
|
C9H11NO
|
|
Furo[2,3-b]pyridine, 5,6-dimethyl- (9CI)
|
105783-88-8
|
C9H9NO
|
|
TEMAFLOXACIN HYDROCHLORIDE
|
105784-61-0
|
C21H18F3N3O3.ClH
|
|
3'-azido-2',3'-dideoxy-5-bromouridine
|
105784-82-5
|
|
|
5-IODO-2',3'-DIDEOXYURIDINE
|
105784-83-6
|
C9H11IN2O4
|
|
BIS(2,2-DIMETHYLPROPOXY)TRIPHENYLPHOSPHORANE
|
105785-75-9
|
C28H37O2P
|
|
Ethanone, 1-(7-methyl-2,4,6-trioxabicyclo[3.2.0]hept-7-yl)-, (1alpha,5alpha,7alpha)- (9CI)
|
105786-16-1
|
C7H10O4
|
|
DIENDO-3-AMINO-BICYCLO[2.2.1]HEPT-5-ENE-2-CARBOXYLIC ACID ETHYL ESTER
|
105786-34-3
|
C10H15NO2
|
|
DIEXO-3-AMINO-BICYCLO[2.2.1]HEPTANE-2-CARBOXYLIC ACID ETHYL ESTER
|
105786-35-4
|
C10H17NO2
|
|
DIEXO-3-AMINO-BICYCLO[2.2.1]HEPT-5-ENE-2-CARBOXYLIC ACID ETHYL ESTER
|
105786-36-5
|
C10H15NO2
|
|
Bicyclo[2.2.1]heptane-2-carboxamide, 3-amino-, (endo,endo)- (9CI)
|
105786-37-6
|
C8H14N2O
|
|
Bicyclo[2.2.1]hept-5-ene-2-carboxamide, 3-amino-, (1R,2S,3R,4S)-rel- (9CI)
|
105786-38-7
|
C8H12N2O
|
|
Bicyclo[2.2.1]heptane-2-carboxamide, 3-amino-, (1R,2S,3R,4S)-rel- (9CI)
|
105786-39-8
|
C8H14N2O
|
|
3-EXO-AMINOBICYCLO[2.2.1]HEPT-5-ENE-2-EXO-CARBOXAMIDE
|
105786-40-1
|
C8H12N2O
|
|
4,5,6,7-Tetrahydro-3-hydroxy-[1,2,3]oxadiazolo[3,4-a]pyridin-8-ium inner salt
|
105786-95-6
|
C6H8N2O2
|
|
1H-Cyclopenta[4,5]pyrrolo[2,3-e]benzimidazole(9CI)
|
105790-42-9
|
C12H7N3
|
|
1-Heptatriacotanol
|
105794-58-9
|
C37H76O
|
|
clitocine
|
105798-74-1
|
C9H13N5O6
|
|
Aziridine, 2-(4-nitrophenyl)-
|
105799-01-7
|
C8H8N2O2
|
|
4-CHLORO-6-FLUORO-2H-BENZOPYRAN-3-CARBOXALDEHYDE
|
105799-69-7
|
C10H6ClFO2
|
|
ETHYL 8-FLUORO-4H-(1)-BENZOPYRANO(4 3-B&
|
105799-70-0
|
C14H11FO3S
|
|
6-Fluoro-2,2-dimethylchroman-4-one
|
105799-73-3
|
C11H11FO2
|
|
4H-4-phenylthieno-(3,2-C)-(1)-benzopyran-2-carboxylate
|
105799-78-8
|
|
|
8-FLUORO-4H-THIENO[3,2-C]CHROMENE-2-CARBOXYLIC ACID
|
105799-81-3
|
C12H7FO3S
|
|
Acetamide, N-(2,3-dihydro-2-oxo-6-benzothiazolyl)- (9CI)
|
105800-72-4
|
C9H8N2O2S
|
|
9-hydroxyestrone-11-nitrate
|
105801-89-6
|
|
|
3'-(2,2,5,5-tetramethyl-3-pyrroline-1-oxyl-3-carbonyl)amino-3'-deoxyguanosine 5'-diphosphate
|
105802-04-8
|
|
|
CHRYSENE, 5-METHYL-6-NITRO-
|
105802-11-7
|
|
|
ETHYL CHLOROFORMATE, [CARBOXYL-14C]
|
105802-19-5
|
C3H5ClO2
|
|
4-DI-2-ASP
|
105802-46-8
|
C18H23IN2
|
|
2-methylestra-4,9-dien-3-one-17-ol
|
105802-53-7
|
|
|
3-(2-OXO-ACETYL)-BENZONITRILE
|
105802-54-8
|
C9H5NO2
|
|
menthyl 3-(2-pyridylsulfinyl)acrylate
|
105802-70-8
|
C18H25NO3S
|
|
H-VAL-ARG-LYS-ARG-THR-LEU-ARG-ARG-LEU-OH
|
105802-82-2
|
C51H100N22O11
|
|
H-PRO-LEU-SER-ARG-THR-LEU-SER-VAL-ALA-ALA-LYS-LYS-OH
|
105802-84-4
|
C56H103N17O16
|
|
splenotritin
|
105803-00-7
|
C17H33N7O6
|
|
5-Bromo-6-chloro-2-methylpyrimidin-4-ol
|
105806-11-9
|
C5H4BrClN2O
|
|
4,6-DICHLORO-5-FLUORO-2-METHYLPYRIMIDINE
|
105806-13-1
|
C5H3Cl2FN2
|
|
4(1H)-PyriMidinone, 6-chloro-5-fluoro-2-Methyl-
|
105806-14-2
|
C5H4ClFN2O
|
|
Efegatran
|
105806-65-3
|
C21H32N6O3
|
|
7-AMINO-2-METHYL-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE
|
105807-79-2
|
C9H10N2O2
|
|
6-AMINO-2-METHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE
|
105807-80-5
|
C9H10N2O2
|
|
7-AMINO-2,2-DIMETHYL-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE
|
105807-83-8
|
C10H12N2O2
|
|
6-AMINO-2,2-DIMETHYL-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE
|
105807-84-9
|
C10H12N2O2
|
|
AMINE-TERMINATED MAGNETIC PARTICLES
|
105808-72-8
|
|
|
|
Carboxy-terminated magnetic particles
|
105808-73-9
|
|
|
SPECTRASYNQ 1621
|
105809-15-2
|
C6H12D6N3P3
|
|
N(6)-2-(4-azido-3-iodophenyl)ethyladenosine
|
105811-49-2
|
C18H19IN8O4
|
|
1,2-DIHYDRO-2-(IODOMETHYL)-NAPHTHALENE
|
105812-53-1
|
C11H11I
|
|
(3S,4R)-4-(4-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine
|
105812-81-5
|
C13H18FNO
|
|
cis-Paroxetine hydrochloride
|
105813-04-5
|
C19H21ClFNO3
|
|
trans N-Benzyl Paroxetine
|
105813-14-7
|
C26H26FNO3
|
|
trans-(-)-3-[(1,3-Benzodioxol-5-yloxy)Methyl]-4-phenyl-1-(phenylMethyl)piperidine Hydrochloride
|
105813-39-6
|
C26H28ClNO3
|
|
Defluoro N-Benzyl Paroxetine
|
105813-40-9
|
C26H27NO3
|
|
hupehenisine
|
105814-56-0
|
C27H41NO3
|
|
barbourgenin
|
105815-87-0
|
C27H44O4
|
|
apigenin-7-O-(6''-O-4-coumaroyl)-beta-glucopyranoside
|
105815-90-5
|
C30H26O12
|